Pandion Therapeutics

OverviewSuggest Edit

Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants. The Company is aimed to create a new generation of drugs with transformative efficacy and safety.

TypePrivate
Founded2017
HQCambridge, US
Websitepandiontx.com

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2020)36(-5%)

Key People/Management at Pandion Therapeutics

Nathan Higginson-Scott

Nathan Higginson-Scott

Director Protein Technologies
Erik Sampson

Erik Sampson

Principal Scientist, Immunology
Lindsay Edwards

Lindsay Edwards

Senior Scientist, Immunology
Daniel Rios

Daniel Rios

Scientist, Immunology
Bridget Larkin

Bridget Larkin

Scientist, Immunology
Jyothsna Visweswaraiah

Jyothsna Visweswaraiah

Scientist, Protein Technologies
Show more

Pandion Therapeutics Office Locations

Pandion Therapeutics has an office in Cambridge
Cambridge, US (HQ)
610 Main St
Show all (1)

Pandion Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Pandion Therapeutics total Funding

$58 m

Pandion Therapeutics latest funding size

$58 m

Time since last funding

2 years ago

Pandion Therapeutics investors

Pandion Therapeutics's latest funding round in January 2018 was reported to be $58 m. In total, Pandion Therapeutics has raised $58 m
Show all financial metrics

Pandion Therapeutics Online and Social Media Presence

Embed Graph

Pandion Therapeutics News and Updates

VC-backed Pandion Therapeutics appoints CEO

Cambridge, Massachusetts-based Pandion Therapeutics, a biotech company focused on treating autoimmune and inflammatory disease, has named Dr. Rahul Kakkar as CEO and a member of its board of directors. Also, Pandion has promoted Dr. Jo Viney, a founder of the company, to president and chief scientif…

Pandion Therapeutics Frequently Asked Questions

  • When was Pandion Therapeutics founded?

    Pandion Therapeutics was founded in 2017.

  • Who are Pandion Therapeutics key executives?

    Pandion Therapeutics's key executives are Nathan Higginson-Scott, Erik Sampson and Lindsay Edwards.

  • How many employees does Pandion Therapeutics have?

    Pandion Therapeutics has 36 employees.

  • Who are Pandion Therapeutics competitors?

    Competitors of Pandion Therapeutics include ImCheck Therapeutics, Breath Therapeutics and AB2 Bio.

  • Where is Pandion Therapeutics headquarters?

    Pandion Therapeutics headquarters is located at 610 Main St, Cambridge.

  • Where are Pandion Therapeutics offices?

    Pandion Therapeutics has an office in Cambridge.

  • How many offices does Pandion Therapeutics have?

    Pandion Therapeutics has 1 office.